4-[(4-chlorobenzyl)oxy]-3-methoxybenzaldehyde, 10g

6-Bromoisoquinoline, 98.0%, 500g

2-Methyl-5-nitro-1H-benzoimidazole, 95.0%, 25g

3-(Trifluoromethyl)pyridine-2-carboxylic Acid>98.0%(GC)(T)100mg

4'-Nitro-[1,1'-biphenyl]-4-amine, 96%, 1g

2-iso-Propoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98.0%, 500g

GC capillary column ROTI®Cap-5, 25 m, 0.25 mm, 1.00 µm, 1 Piece(s)

tert-Butyl (trans-2-hydroxycyclohexyl)carbamate, 95.0%, 250mg

(R)-4-METHYL-2-(HYDROXYMETHYL)MORPHOLINE, 97.0%, 1g

1-(1,4-diazepan-1-yl)-3,3-dimethylbutan-1-one, 95.0%, 1g

1-Pyrrolidinecarboxylic acid, 3,4-dihydroxy-, phenylmethyl ester,(3S,4S)-, 98%, 250mg

(2-amino-4-methyl-1,3-thiazol-5-yl)acetic acid, 95.0%, 1g

N-Boc-Morpholine-2-carboxylic acid, 95.0%, 25g